Finance

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28%

Jun 23, 2025 - 21:33
 0  0
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28%
Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the "false guise" of personalization.
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0

Related Posts

How Fanatics is teaching business acumen to pro athletes

How Fanatics is teaching business acumen to pro athletes

Jun 24, 2025  0  0

Streaming surpasses combined broadcast and cable viewing for first time ever

Streaming surpasses combined broadcast and cable viewin...

Jun 17, 2025  0  1

PGA Tour names NFL's Brian Rolapp as CEO to succeed Commissioner Jay Monahan

PGA Tour names NFL's Brian Rolapp as CEO to succeed Com...

Jun 17, 2025  0  1

Kroger's shares rise as grocer says shoppers seek lower prices, cook more at home

Kroger's shares rise as grocer says shoppers seek lower...

Jun 20, 2025  0  0

Major U.S. health insurers say they will streamline controversial process for approving care

Major U.S. health insurers say they will streamline con...

Jun 23, 2025  0  0

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%

Novo Nordisk ends deal with Hims & Hers over sales of W...

Jun 24, 2025  0  0